June 22 (SeeNews) - Bulgarian drug maker Sopharma [BUL:SFA] said on Tuesday that its CEO Ognyan Donev acquired 1,600 shares in the company at a weighted average price of 3.64 levs ($2.26/1.86 euro) apiece.